nps-568 has been researched along with Disease Exacerbation in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 5 (83.33) | 29.6817 |
| 2010's | 1 (16.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, NX; Duan, D; Gattone, VH; Henley, C; Martin, D; Moe, SM; Seifert, MF; Sinders, RM | 1 |
| Torres, VE | 1 |
| Akizawa, T; Hosaka, N; Kinugasa, E; Koiwa, F; Kondo, F; Kumata, C; Mizobuchi, M; Nakazawa, A; Ogata, H | 1 |
| Amann, K; Odoni, G; Ogata, H; Orth, SR; Ritz, E | 1 |
| Dikow, R; Gross, ML; Ritz, E | 1 |
| Akizawa, T; Kinugasa, E; Koiwa, F; Ogata, H | 1 |
2 review(s) available for nps-568 and Disease Exacerbation
| Article | Year |
|---|---|
Role of calcium-phosphorous disorders in the progression of renal failure.
Topics: Aniline Compounds; Animals; Calcitriol; Calcium; Chronic Disease; Disease Progression; Fibroblast Growth Factor-23; Humans; Hypercalcemia; Hyperthyroidism; Kidney; Kidney Diseases; Kidney Failure, Chronic; Mesangial Cells; Parathyroid Hormone; Parathyroidectomy; Phenethylamines; Phosphates; Podocytes; Propylamines; Vitamin D | 2005 |
CKD-MBD: impact on management of kidney disease.
Topics: Aniline Compounds; Bone Diseases, Metabolic; Calcium Metabolism Disorders; Cardiovascular Diseases; Chelating Agents; Cinacalcet; Disease Progression; Humans; Hyperparathyroidism, Secondary; Hyperphosphatemia; Lanthanum; Naphthalenes; Phenethylamines; Polyamines; Propylamines; Renal Insufficiency, Chronic; Sevelamer; Vitamin D; Vitamin D Deficiency; Vitamins | 2007 |
4 other study(ies) available for nps-568 and Disease Exacerbation
| Article | Year |
|---|---|
Calcimimetic inhibits late-stage cyst growth in ADPKD.
Topics: Aniline Compounds; Animals; Calcium; Disease Models, Animal; Disease Progression; Dose-Response Relationship, Drug; Fibrosis; Hyperparathyroidism; Kidney; Male; Parathyroid Hormone; Phenethylamines; Polycystic Kidney Diseases; Propylamines; Rats; Rats, Inbred Strains; Receptors, Calcium-Sensing; Severity of Illness Index | 2009 |
Type II calcimimetics and polycystic kidney disease: unanswered questions.
Topics: Aniline Compounds; Animals; Calcium; Calcium Gluconate; Disease Models, Animal; Disease Progression; Male; Phenethylamines; Polycystic Kidney Diseases; Propylamines; Rats | 2009 |
Effects of calcimimetic combined with an angiotensin-converting enzyme inhibitor on uremic cardiomyopathy progression.
Topics: Angiotensin-Converting Enzyme Inhibitors; Aniline Compounds; Animals; Calcium; Cardiomyopathies; Disease Progression; Drug Therapy, Combination; Enalapril; Male; Phenethylamines; Propylamines; Rats; Rats, Sprague-Dawley; Uremia | 2011 |
Beneficial effects of calcimimetics on progression of renal failure and cardiovascular risk factors.
Topics: Aniline Compounds; Animals; Blood Pressure; Calcium; Cardiovascular Diseases; Disease Progression; Hyperparathyroidism, Secondary; Kidney; Lipid Metabolism; Male; Models, Animal; Myocardium; Parathyroidectomy; Phenethylamines; Propylamines; Rats; Rats, Sprague-Dawley; Renal Insufficiency; Risk Factors; Ventricular Remodeling | 2003 |